VOQP (VioQuest Pharmaceuticals) Net-Net Working Capital : $-1.10 (As of Jun. 2008)

VioQuest Pharmaceuticals Net-Net Working Capital Chart

VioQuest Pharmaceuticals Annual Data
	Trend	Dec98	Dec99	Dec00	Dec01	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07
Net-Net Working Capital		Get a 7-Day Free Trial					-0.02	1.35	0.85	-0.01	-0.94

VioQuest Pharmaceuticals Quarterly Data
	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08
Net-Net Working Capital	Get a 7-Day Free Trial															-0.51	-0.57	-0.94	-1.30	-1.10

Competitive Comparison of VioQuest Pharmaceuticals's Net-Net Working Capital

For the Biotechnology subindustry, VioQuest Pharmaceuticals's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VioQuest Pharmaceuticals's Price-to-Net-Net-Working-Capital Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VioQuest Pharmaceuticals's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where VioQuest Pharmaceuticals's Price-to-Net-Net-Working-Capital falls into.

VioQuest Pharmaceuticals Net-Net Working Capital Calculation

VioQuest Pharmaceuticals's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2007 is calculated as

VioQuest Pharmaceuticals's Net-Net Working Capital (NNWC) per share for the quarter that ended in Jun. 2008 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.

VioQuest Pharmaceuticals  (OTCPK:VOQP) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.

VioQuest Pharmaceuticals Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of VioQuest Pharmaceuticals's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

VioQuest Pharmaceuticals Business Description